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Introduction
Several studies evidenced the important role of vasculari-
zation in supporting the survival of free fat graft.1,2 
However recently, the significance of inflammatory 
cytokines was observed as mediators of free fat cells’ sur-
vival and integration.3,4 In particular, the interaction 
between vascularization and inflammatory cytokines may 
be fundamental for free fat cells’ survival and functional-
ity. The latter is of particular importance when autologous 
fat grafting is performed for regenerative purpose.
An interesting finding described by Hamed et al.5 is that 
a trophic stimulation for free fat cells’ functional activation 
should have origin inside the free fat cells due to the fact 
that factors administered externally failed to reach their 
effects. These findings lead us to hypothesize that free fat 
cells are a complex milieu in which cytokine balance is 
essential for the therapeutic results of autograft.
The use of adipose tissue mass to support regenerative 
medicine imply the release of cytokine that can initiate the 
restoring tissue functionality, known that in several tissue 
districts the alteration of signalling factors is at the basis of 
an impaired organ healing.6,7
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Following these findings, a lot of studies have focussed 
their attention on the properties of adipose-derived stem 
cells (ASC) to secrete several cytokines as important event 
to promote tissue healing.8 Indeed, also other adipose tis-
sue-resident cells such as macrophages and lymphocytic 
cells are able to produce cytokines.9 These findings suggest 
that free fat cells may represent a trophic milieu in which 
the different cell types of the adipose depots participate by 
cytokine secretion to perform trophic/regenerative effects.
In a previous work, we have observed that free fat cells 
used for refilling is sensible to erythropoietin (EPO) 
administration.10 EPO is a glycoprotein hormone that was 
first characterized by its ability to stimulate erythropoie-
sis. EPO has also the ability to affect immunological 
mechanisms.11 Dendritic cells, which initiate the immune 
response, are targets of the immunomodulatory function 
of EPO,12 macrophages are also influenced by EPO.13 
Katz et al.14 have also reported that EPO has anti-inflam-
matory effects in different animal models, decreasing 
apoptosis and reducing the expression of pro-inflamma-
tory cytokines.
The paper of Hamed et al.5 is the first article reporting 
the effect of EPO on human free fat grafting. This article 
well describes the effect of EPO on inflammation after fat 
grafting as one of the mechanisms by EPO to enhance 
graft attachment in the receiving site.
In conclusion, EPO can be considered as a tissue-pro-
tective hormone with pleiotropic potential, it interferes 
with the activities of pro-inflammatory cytokines and 
stimulates healing following injury, preventing the tissue 
destruction surrounding the injury site.11
The aim of this work is to identify the potentiality of the 
human free fat grafts to react as trophic/reparative support. 
For this purpose, the cytokine profile expressed following 
inflammatory stimulus such as the bacterial lipopolysac-
charides (LPS) have been analysed and compared with the 
cytokine profile expressed following EPO administration.
Materials and methods
Isolation and preparation of human fat tissue
Fat graft was harvested using manual suction lipectomy 
through a 14-gauge blunt cannula, under general anaesthe-
sia, from abdomen areas of 8 women during procedures of 
reconstructive surgery. The over-exceeding free fat cells, 
not used for refilling and destined to disposal, were used in 
our study. Therefore, no ethical committee was required to 
authorize the study. All participants gave their written 
informed consent. The patients were 42 ± 4 years old. In 
order to decrease bleeding during fat aspiration and to 
relieve pain after the procedure, the aspiration areas were 
injected with a local anaesthesia solution containing lido-
caine (0.5%) and adrenaline (1:1,000,000) before the fat 
graft aspiration. From each of the eight patients, more than 
100 mL of adipose mass was aspirated and centrifuged for 
2 min at 1500 r/min according to Coleman’s modified pro-
cedure.10 The upper fraction representing oil and cellular 
fragments together with the lower fraction representing the 
plasma and local anaesthetic were separated from the cen-
tral fraction consisting of adipose mass; the latter was used 
in the study. Lipoaspirate-Coleman (1 mL) corresponding 
to 1.00 ± 0.04 g of tissue was cultured in 2 mL of X-VIVO 
15 medium (Lonza) in a CO2 incubator at 5% CO2, 37°C 
for 48 h. From each sample three experimental groups 
were prepared: EPO-treated group, 48 h of treatment in 
culture media with 0.60 µg/mL of EPO (EPREX, Janssen-
Cilag, Milan, Italy); LPS-treated group, 48 h of treatment 
in culture media with LPS 100 ng/mL (Sigma), used as 
positive inflammatory control; control group, without any 
treatment used as negative control.
Cytokine release
The cytokines release was assessed using a sandwich 
ELISA kit that enables perceiving and semi-quantifying 
the proteins released (Mouse Cytokine Antibody Array-
Panomics; Affymetrix, Santa Clara, CA, USA). Briefly, 
the media of lipoaspirate-Coleman cultured with or with-
out EPO and LPS were incubated on array membranes 
containing linked antibodies. In this way, specific cytokine 
proteins are being immobilized. Then a detection biotin-
conjugated antibody binds to a second epitope on the pro-
tein, creating an antibody ‘sandwich’ around the cytokine. 
After streptavidin-HRP incubation, membranes were ana-
lysed using a VersaDoc Imaging System Model 3000 
(BioRad). A semi-quantitative analysis was performed 
detecting positive spot as fold increase compared to nega-
tive control by VersaDoc. Then, instrumental data were 
normalized for the optical fundus, converted and reported 
as % of optical density (%OD).
Data analysis
The Kolmogorov–Smirnov statistical test was used for the 
assessment of data normal distribution. Statistical signifi-
cance was determined by one-way analysis of variance, 
the Newman–Keuls post hoc comparison tests were used 
to test significance between experimental groups. The sig-
nificance level was set at p < 0.05. All statistical tests were 
performed by the statistical software program Prism 2.01 
(GraphPad Software, La Jolla, CA, USA).
Results
The several cytokines analysed were classified according to 
their activities in five groups as shown in Table 1: ‘pro-
inflammatory’, ‘anti-inflammatory’, ‘chemokines’, ‘growth 
factors’ and ‘other’.
In the adipose mass of the control untreated group, we 
have observed that the pro-inflammatory factors were not 
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expressed, with the only exception of limited levels of 
interleukin (IL)-12(p40), while anti-inflammatory factors 
and chemokines were represented, respectively, by IL-6, 
IL-8 and macrophage inflammatory protein (MIP)-1β. 
Vascular endothelial growth factor (VEGF) was the only 
growth factor detected in control free fat cells. In particu-
lar, in the control group, we have detected high levels of 
leptin, matrix metalloproteinase (MMP)-3, VEGF, IL-6 
and IL-8. IL-8 was the highest expressed IL instead of 
MIP-1β and IL-12(p40) that were detected in lower levels 
(Figures 1(a) and 2).
Cultured lipoaspirate resulted to be vital and active, in 
fact it demonstrates to modify the pattern of cytokines 
released when stimulated with LPS, used as pro-inflamma-
tory factor (Figure 1(b)). When the cytokine pattern was 
compared to the control untreated one, considered the 
basal secretor activity, we have detected a significant 
increase of IL-12(p40), IL-6, MIP-1β, VEGF and leptin, 
while IL-8 and MMP-3 did not rise. The analysis of the 
group of the pro-inflammatory factors revealed that an 
increase in IL-12(p40) along with cytotoxic T-lymphocyte 
antigen (CTLA) and intracellular adhesion molecule 
(ICAM)-1 was detected; in the group of the anti-inflamma-
tory factors, the same factors observed in the control group 
were present with the occurrence of further factors such as 
IL-10 and IL-1 receptor antagonist (IL-1Ra). The same 
chemokines observed in the control group were detected 
after LPS stimulation, with the presence of further 
chemokines such as interferon gamma-induced protein 
(IP)-10, MIP-1α and regulated on activation normal T cells 
expressed and secreted (RANTES). Even in LPS-group, 
VEGF represented the only growth factors detected, 
among those tested, whereas leptin and MMP-3 were the 
‘other’ factors detected (Figures 1(b) and 2).
The EPO stimulated lipoaspirate (Figure 1(c)), similarly 
to the control group, released in culture media CTLA, and 
IL-12(p40) as pro-inflammatory factors; IL-6 as anti-
inflammatory factor; whereas chemokines were repre-
sented by IL-8, MIP-1α and MIP-1β. Furthermore, in the 
EPO-group, VEGF represented the only growth factors 
detected among those tested, whereas leptin and MMP-3 
were the factors detected in the group ‘other’ (Figures 1(c) 
and 2). In particular, EPO stimulation increased the expres-
sion of CTLA more than LPS dose without increasing the 
release of IL-12(p40), which maintains a level similar to 
control untreated lipoaspirate. The anti-inflammatory 
interleukin IL-6 and the growth factor VEGF were detected 
similar to LPS-group and therefore increased, in com-
parison to levels detected in the control group. Among 
chemokines, IL-8 resulted unmodified in comparison to 
control and LPS- group, whereas MIP-1β and leptin were 
further increased with respect to LPS-group. No variation 
in the quantity of MMP-3 was observed comparing EPO, 
control and LPS-group (Figures 1 and 2).
Discussion
The most recent acquisition of the inflammatory processes 
and the discovery of the occurrence of numerous factors 
involved in cell recruitment and/or activation signalling 
have gained new functions. Therefore, the same factors 
previously considered as strictly pro-inflammatory are 
also been considered protective and reparative factors.15 
Therefore, the occurrence of factors secreted in a remodel-
ling tissue need to be analysed inside the pool of factors 
with which they operate.
We have observed that the free fat cells, following 
withdrawal, released several factors involved in immu-
nomodulatory processes such as IL-6, IL-8, IL-12(p40) 
and MIP-1β, but it also releases factors active in repara-
tive/regenerative pathways such as MMP-3, VEGF and 
Leptin. Even if factors such as IL-6, IL-8, IL-12(p40) and 
MIP-1β are recognized as pro-inflammatory cytokines 
and chemokines, for some of these factors, such as IL-6, 
IL-8 and MIP-1β an exclusive pro-inflammatory role 
has been recently questioned.15–18 Trujillo et al.19 have 
observed that cultures of human adipose tissue with IL-6 
increased Leptin and lipolysis together with a decrease in 
lipoprotein lipase activity, suggesting a direct metabolic 
and physiologic effect performed by this cytokine into 
adipose tissue.
Otherwise, IL-8 and MIP-1β are cell-attracting 
chemokines important in recruiting immune cells such as 
Table 1. Grouped list of several factor detected in 
supernatants of fat mass cultures.
Pro-
inflammatory
Anti-
inflammatory
Chemokines Growth 
factors
Other
CTLA IL-4 Eotaxin EGF Apo/Fas
IFN-γ IL-5 IL-8 GM-CSF Leptin
IL-1α IL-6 IP-10 IL-3 MMP-3
IL-1β IL-10 MIP-1α IL-7  
IL-2 IL-6R MIP-1β VEGF  
IL-12(p40) TGF-β MIP-4  
IL-15 IL-1Ra MIP-5  
IL-17 RANTES  
ICAM-1  
VCAM-1  
TNF-α  
TNFRI  
TNFRII  
Apo/Fas: apoptosis antigen-1/Fas; CTLA: cytotoxic T-lymphocyte antigen; 
IL: interleukin; EGF: epidermal growth factor; IFN-γ: interferon-γ; 
GM-CSF: granulocyte-macrophage colony-stimulating factor; IP-10: 
induced protein-10; MMP: matrix metalloproteinase; MIP: macrophage 
inflammatory protein; VEGF: vascular endothelial growth factor; TGF-β: 
transforming growth factor-β; RANTES: regulated on activation normal 
T cells expressed and secreted; ICAM-1: intracellular adhesion  
molecule-1; VCAM-1: vascular cell adhesion molecule-1; TNF-α: 
tumour necrosis factor-α; TNFRI: tumour necrosis factor receptor 1; 
TNFRII: tumour necrosis factor receptor II.
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macrophages (in particular MIP-1β) and lymphocytes. 
Indeed nevertheless the undoubted inflammatory role of 
these cells, recently their role in reconstructive/reparative 
pathways has been hypothesized. In fact it has been 
observed that IL-8 and MIP-1β act also as recruiting neu-
trophils and natural killer (NK) cells, which represent an 
important cellular types in performing protective and 
reparative functions in healing tissues.16,18,20,21 Nevertheless 
the specific role of MMP-3, VEGF and Leptin, these 
factors also have shown to be secreted by cells in response 
to tissue damage.
MMP-3 is an important factor directly secreted by mono-
cytes/macrophages that participate in matrix repairing and 
remodelling, while the scavenger and protective functions of 
macrophages are performed.22 VEGF is a well-known factor 
responsible to ameliorate the perfusion of tissue, secreted by 
endothelia cells, it is important in organ regeneration and 
homeostasis, and its secretion increases following tissue 
Figure 1. Image showing the multitest to detecting cytokines released on surnatant of free fat cells culture following 48 h. (a) 
control group, (b) LPS-treated group and (c) EPO-treated group. The table shows the legend of paired dot spot visible or not visible 
on membranes.
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stress or injury.23 Leptin is a peptide hormone produced by 
adipocytes, it has pleiotropic effects exerting its influence 
on energetic metabolism and psychological behaviour, but it 
has also been suggested to have a role as paracrine factors 
inside adipose tissue recovering and sustaining physiologi-
cal function of adipose tissue.24
Collecting these findings, we hypothesize that human 
adipose tissue, in form of lipoaspirate, produces specific 
cytokines in vitro. Implanted lipoaspirate might protect the 
tissue homeostatic mechanism, probably activating mac-
rophage, fibroblast and lymphocytes that might be resident 
or could be recruited into the regenerating tissue. 
Considering that these factors are also active during 
inflammatory process, they could be responsible of the 
development inflammatory events or respond modifying 
their release factors during inflammatory events.
To test this hypothesis, we have administered LPS to 
cultured lipoaspirate, a well-known inflammation inductor 
Figure 2. Bar graphs showing the results of semi-quantitative analysis of visible dot spot.
CTR: control group; LPS: LPS-treated group; EPO: EPO-treated group. ap < 0.05 versus CTR-group, bp < 0.05 versus LPS-group.
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factor. The cultured free fat cells showed the secretion of 
new factors or the increased release of some observed in 
the control group. In particular, we have observed the 
secretion of new cytokines such as CTLA, RANTES, 
IP-10, MIP-1α, IL-10 and IL-1Ra.
CTLA is a factor responsible for regulating inhibitory sig-
nal-activated lymphocytes; it is generally found during the 
first phase of inflammatory process where it acts as regulatory 
and homeostatic factor of inflammatory process. RANTES is 
a known pro-inflammatory cytokine belonging to the group 
of chemokines that acts by promoting the recruitment and 
activation of inflammatory cells such as monocytes, lympho-
cytes, mast cells and eosinophils,25 whereas IP-10 is a chem-
oattractant for NK cells and T cells and is believed to be an 
important regulator of the Th1, IL-12-driven, inflammatory 
response as an inducer of cellular infiltration.15
MIP-1α and MIP-1β are major factors produced by 
fibroblasts and macrophages after the stimulation with bacte-
rial endotoxin. They are crucial factors for immune responses 
towards infection and inflammation.26 However, differently 
from MIP-1β, for MIP-1α a role in reparative functions has 
not been proven. Therefore, MIP-1α seems to deserve spe-
cifically the identity of pro-inflammatory cytokine.
Being LPS an inflammatory stimulus, we demonstrated 
that lipoaspirate modifies its cytokines pattern during 
inflammation and some factors such as IL-6, IL-8, 
IL-12(p40), MIP-1β, MMP-3 and VEGF could have both 
inflammatory and regenerative effect. In this term, the 
presence of other factors became determinant to address 
the action of this group of ambivalent factors. The low 
expression of well-known anti-inflammatory cytokines 
such as Il-10 and IL-1Ra can be interpreted as a confirma-
tion of the molecular pathways focussed to perform a bal-
anced inflammatory reaction.
Of interest, the increase in Leptin production following 
LPS adipose tissue stimulation may be the reflex of the 
immunomodulatory function on leukocytes observed for 
this hormone,27 giving Leptin also an identity of an LPS-
inducible inflammatory cytokine.
Following the EPO administration, the presence of fac-
tors such as CTLA, the high level of MIP-1β and the 
absence of RANTES induce to hypothesize the occurrence 
of factors having a role in recovering leukocytes involved 
in regenerative/reparative functions rather than inflamma-
tion. Whereas the presence in this experimental group of 
MMP-3, VEGF, IL-6 and IL-8 induces to consider this 
group of factors in term of reparative signals rather than 
inflammatory signals as previously discussed. Following 
this hypothesis, we also suggest that the high levels 
detected for Leptin should indicate its action in terms of 
regenerative/reparative signals.
Conclusion
In conclusion, the free fat cells’ withdrawal from its natu-
ral place (lipoaspirate) and its injection into the receiving 
site during reconstructive surgery is the basis of a poten-
tial development of inflammatory response. This kind of 
reaction at the receiving site has been considered the 
main cause for free fat cells’ transplantation failure or 
unpredictability in volume keeping.3,4 Otherwise, the 
occurrence of a trophic factors such as EPO may help to 
inhibit the potential inflammatory process development 
and stimulate the activation of reparative/regenerative pro-
cess starting from the same ambivalent factors occurring 
during the first period of stress.
Perspective for in vivo application of EPO for 
autologous fat grafting
The paper of Hamed et al.5 is the first article reporting the 
effect of EPO on human free fat grafting performed on 
nude mice. In his work, Hamed has observed that treat-
ment of the fat grafts with EPO, in a dose-dependent man-
ner, increased the expression levels of various angiogenic 
factors, such as VEGF, basic fibroblast growth factor 
(bFGF), platelet derived growth factor-BB (PDGF-BB), 
MMP-2 and insulin growth factors-1 (IGF-1). The 
increased expression of these factors was accompanied 
with an increase in microvascular density. Induction of cell 
survival factor expression such as protein kinase B (PKB) 
and the reduction in the fat cell apoptosis extent were also 
observed. Contemporary, the authors have also observed 
reduction in the inflammatory response detected by CD68-
positive cells. These findings highlighted the importance 
of EPO treatment in performing angiogenesis in free fat 
grafting and in increasing the survival of grafted fat cells.
In our work, we confirm and extend this last observation 
in an in vitro culture of free fat cells, highlighting that EPO 
administration is able to decrease inflammatory factors and 
induce the expression of reparative factors. In particular, we 
have observed the susceptibility of fat cells to inflammatory 
stimuli and the consequent expression of inflammatory fac-
tors that may represent the signals inducing cell apoptosis, 
microvascular alteration and failure of the fat graft.
Indeed the inflammatory stimulus performed in our in 
vitro model represents a strong direct stimulus that may be 
not similar to that happened in vivo system. However, the 
involved cytokines are the same known to mediate the 
inflammatory stimulus in tissue. Furthermore, the use of the 
same materials used during the lipofilling procedure leads 
us to hypothesize that the observed response could be the 
same to the one we may obtain in vivo experimental model.
In summary, we hypothesize that the LPS-induced 
inflammatory factors and the EPO-induced regenerative/
reparative factors observed in vitro in our experimental 
conditions may well reflect what may occur in vivo. 
Otherwise, the perfusion of the free fat cells in vitro and in 
vivo is widely different and the EPO administration per-
formed in vitro should be recalibrated to be adapted to in 
vivo condition to determine the effect of EPO and its appli-
cation in clinical practice.
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Final consideration
Autologous fat grafting is an important procedure in clini-
cal practice, but the problems related to the long-term graft 
survival and its unpredictability are the most important 
limit of this technique in the clinical practice. Numerous 
studies have been carried out to establish a protocol that 
induces a fat cell selection with the aim of receiving a bet-
ter response of fat graft28 or to perform technical solution 
to have a more compliance free fat cells to use in grafting 
procedure.28,29 Recently, attention was dedicated to drugs 
or biological factors that could help the surviving and inte-
gration of free fat cells. EPO has been shown to be one of 
the most promising agents.
EPO is a well-known agent that has recently received 
numerous evidence on its trophic effects on vasculature, cell 
surviving and, following our evidence, anti-inflammatory 
protective agent.
EPO is an approved drug, the use of which contem-
plates subcutaneous injections that can also be done at the 
receiving site of fat grafting. This occurrence has made 
easy the repurposing of EPO for the use in autologous fat 
grafting enhancement. Following the emerging findings on 
the safety and properties of EPO, it may be of interest to 
study clinical setting in EPO administration to improve the 
free fat grafting integration.
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